NIH study identifies promising COVID-19 treatments
Washington – The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched …
Continue readingWashington – The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched …
Continue readingPalo Alto – Tesla Inc has agreed to acquire German ATW Automation, a supplier assembling battery modules and packs for …
Continue readingWashington – A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine …
Continue readingBEIJING – China has approved a wealth management joint venture between U.S. asset manager BlackRock Inc, Singapore state investor Temasek …
Continue readingWashington – The investigational vaccine known as mRNA-1273 protected mice from infection with SARS-CoV-2, the virus that causes COVID-19, according …
Continue reading